Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
Program Type: ASHP accredited two-year residency (PGY 1 and PGY 2)
ASHP Match Number: 141419
Purpose: This specialized residency in Pharmacotherapy is a 2-year specialty residency designed to prepare pharmacists for practice at the level of a pharmacotherapy specialist. Via institutionally-based and ambulatory care experiences, it fosters knowledge and refines clinical skills across all areas of pharmacotherapy. Graduates of this program will be highly qualified independent practitioners, with an advanced degree of proficiency and expertise in the delivery of pharmaceutical care to diverse patient populations. In addition, pharmacists graduating this program can be expected to successfully sit for board certification (BCPS), perform practice-related research, and serve patients, providers, and institutions as an authoritative resource on pharmacotherapy matters as a pharmacy clinical specialist in an academic or community hospital or clinical faculty at a college or university.
Program Overview: : The Pharmacotherapy Residency includes core rotations and longitudinal experiences chosen to establish a strong clinical base across a variety of patient care areas in the inpatient and outpatient settings. The specific program for each resident may vary in structure and area of emphasis based upon the resident’s entry level of knowledge, skills and interest. The resident has the opportunity to gain additional experiences outside of the core rotations through electives of his/her choice. The Pharmacotherapy Resident has staffing opportunities in the medicine pharmacy during his/her first year, and in the surgery or pediatric pharmacy during his/her second year.
During the program, the resident must complete a self-directed research project in order to demonstrate proficiency in clinical research. The scope, magnitude and type of project may vary according to individual interests, but must be completed in a manner suitable for presentation and manuscript publication. The Pharmacotherapy Resident completes the teaching certificate program through the University of Maryland School of Pharmacy (UMD SOP) which involves serving as a co-preceptor for an APPE student on rotation, leading a lecture at the UMD SOP, completing the course Educational Theory and Practice, small group discussions with students, and developing a teaching portfolio.
- Development of patient care skills
- Present at professional meetings
- Teaching experiences, both didactic and student precepting opportunities, through affiliation with the University of Maryland School of Pharmacy
- Completion of a drug utilization evaluation and contribution to the medical literature
- Completion of a clinical research project
- Longitudinal outpatient clinics
- Participate in interdisciplinary committees and pharmacotherapy topic discussions
- Core Rotations:
- Internal Medicine
- Emergency Medicine
- Infectious Diseases
- Pain Management
- Oncology (Medical Oncology or Herne Malignancy)
- Outcome Research
- Practice Management/Med Safety/DI
- Clinical Practice Mgmt/Drug Policy
- General Pediatrics
- Pediatric Intensive Care-Must be immediately preceded by General Pediatrics
- Neonatal Intensive Care Unit
- Critical Care (CCU, MICU, SICU, CSICU, NCCU)
should be preceded by Infectious Diseases and must be preceded by 1 month of internal Medicine
- Elective Rotations:
- Cardiac critical care (CCU) **
- Clinical Practice Mgmt/Drug Policy **
- Emergency Medicine**
- Hematologic Malignancies **
- Infectious Diseases/Antimicrobial Management **
- Internal Medicine **
- Medical Intensive Care (MICU) **
- Medical Oncology **
- Neuro Critical Care (NCCU) **
- Outcomes research **
- Pain Management **
- General Pediatrics **
- Pediatric Intensive Care (PICU/NICU) **
- Abdominal Transplantation**
- Advanced Heart Failure and Heart Transplantation**
- Pulmonary Hypertension and Lung Transplantation**
- Surgical Intensive Care (SICU) **
- Cardiac Surgery ICU (CSICU)**
** Although these elective rotations meet the required core rotations, the resident may repeat the rotation if approved by the program director.
All applications will be accepted through PHORCAS
Vi Gilmore, PharmD, BCPS
Clinical Pharmacy Specialist, Internal Medicine
Program Director, Pharmacotherapy Residency
600 N. Wolfe Street, Carnegie 180
Baltimore, MD 21287-6180
Dr. Gilmore is an Internal Medicine Clinical Pharmacy Specialist at The Johns Hopkins Hospital. She is also the Director of the PGY 1&2 Pharmacotherapy Residency Program at Johns Hopkins and serves as Clinical Assistant Professor at the University of Maryland School of Pharmacy. Dr. Gilmore received her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill, and completed her Pharmacy Practice and Internal Medicine Residencies at Virginia Commonwealth University Health System in Richmond, Virginia.
Dr. Gilmore is a member of the American Society of Health-System Pharmacists, American College of Clinical Pharmacy, and Maryland Society of Health-System Pharmacy. Dr. Gilmore has practice and research interests in inpatient and outpatient anticoagulation management and transitions of care.